Collagenase and gelatinase activities in bronchoalveolar lavage fluids during bleomycin-induced lung injury

Journal of Pathology

Volumn 185, Issue 3, 1998, Pages 319-323

  Bakowska, J ^a   Adamson, I Y R ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Bleomycin; Epithelial repair; Lung; Metalloprotease

Indexed keywords

BLEOMYCIN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 3; COLLAGEN TYPE 4; COLLAGENASE; GELATINASE;

ANIMAL CELL; ARTICLE; BASEMENT MEMBRANE; CELL PROLIFERATION; COLLAGEN DEGRADATION; ENZYME ACTIVITY; LUNG ALVEOLUS EPITHELIUM; LUNG INJURY; LUNG LAVAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; AUTORADIOGRAPHY; BASEMENT MEMBRANE; BLEOMYCIN; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CELL DIVISION; COLLAGEN; COLLAGENASES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME TESTS; EPITHELIAL CELLS; GELATINASES; MACROPHAGES, ALVEOLAR; MALE; MATRIX METALLOPROTEINASE 2; METALLOENDOPEPTIDASES; NEUTROPHILS; PULMONARY ALVEOLI; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0031851550     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199807)185:3<319::AID-PATH114>3.0.CO;2-L     Document Type: Article

References (25)

1. Crouch E. Pathobiology of pulmonary fibrosis. Am J Physiol 1990; 259: L159-L184.
2. McGowan SE. Extracellular matrix and the regulation of lung development and repair. FASEB J 1992; 6: 2895-2904.
3. Stetler-Stevenson WG. Dynamics of matrix turnover during pathologic remodelling of the extracellular matrix. Am J Pathol 1996; 148: 1345-1350.
4. Laurent GJ, McAnulty RJ. Protein metabolism during bleomycin induced pulmonary fibrosis in rabbits. In vivo evidence for collagen accumulation because of increased synthesis and decreased degradation of the newly synthesized collagen. Am Rev Respir Dis 1983; 128: 82-88.
5. Arden MG, Adamson IYR. Collagen synthesis and degradation during the development of asbestos-induced pulmonary fibrosis. Exp Lung Res 1992; 18: 9-20.
6. Adamson IYR, King GM, Bowden DH. Collagen breakdown during acute lung injury. Thorax 1988; 43: 562-568.
7. Christner P, Fein A, Goldberg S, Lippmann M, Abrams W, Weinbaum G. Collagenase in the lower respiratory tract of patients with adult respiratory distress syndrome. Am Rev Respir Dis 1985; 131: 690-695.
8. Delcaux C, D'ortho MP, Delacourt C et al. Gelatinases in epithelial lining fluid of patients with adult respiratory distress syndrome. Am J Physiol 1997; 16: L442-L451.
9. Taipale J, Keski-oja J. Growth factors in the extracellular matrix. FASEB J 1997; 11: 51-59.
10. Vukicevic S, Kleinman HK, Luyten FP, Roberts AB, Roche NS, Reddi AH. Identification of multiple active growth factors in basement membrane matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. Exp Cell Res 1992; 202: 1-8.
11. Adamson IYR, Young L. Alveolar type II cell growth on a pulmonary endothelial extracellular matrix. Am J Physiol 1996; 270: L1017-L1022.
12. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin-phenol reagent. Eur J Biol Chem 1951; 193: 265-275.
13. Woessner JF. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch Biochem Biophys 1961; 93: 440-447.
14. Adamson IYR, Bowden DH. The type 2 cell as progenitor of alveolar epithelial regeneration. Lab Invest 1974; 30: 35-42.
15. 14C-labeled soluble collagen as substrate. Biochim Biophys Acta 1976; 445: 753-762.
16. Salo T, Liotta LA, Tryggvason L. Purification and characterization of a murine basement membrane collagen degrading enzyme secreted by metastatic tumor cells. J Biol Chem 1983; 258: 3058-3063.
17. Arden MG, Spearman MA, Adamson IYR. Degradation of type IV collagen during the development of fetal rat lung. Am J Respir Cell Mol Biol 1993; 9: 99-105.
18. Adamson IYR. Drug-induced pulmonary fibrosis. Environ Health Perspect 1984; 55: 25-36.
19. O'Connor CM, FitzGerald MX. Matrix metalloproteases and lung disease. Thorax 1994; 49: 602-609.
20. Denholm EM, Rollins SM. Alveolar macrophage secretion of a 92-kDa gelatinase in response to bleomycin. Am J Physiol 1993; 265: L581-L585.
21. Hayashi T, Stetler-Stevenson WG, Fleming MV et al. Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. Am J Pathol 1996; 149: 1241-1256.
22. Adamson IYR, Young L, Bakowska J. Enhanced alveolar type II cell growth on a pulmonary endothelial matrix over fibroblasts. Am J Physiol 1997; 272: L413-L417.
23. Kovacs EJ, Kelley J. Secretion of macrophage derived growth factor during acute lung injury induced by bleomycin. J Leuk Biol 1985; 137: 1-14.
24. Khalil N, Bereznay O, Sporn M, Greenberg AH. Macrophage production of transforming growth factor β and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med 1989; 170: 727-737.
25. Leibler JM, Picou MA, Qu ZH, Powers MR, Rosenbaum JT. Altered immunohistochemical localization of basic fibroblast growth factor after bleomycin induced lung injury. Growth Factors 1997; 14: 25-38.